You are here

Clinical Trials: Trauma

Comment

Discuss

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Wednesday, November 9, 2016 - 12:00
Condition:   Wound, Nonpenetrating
Interventions:   Device: Transpose ® RT System;   Other: debridement/dressing of wound
Sponsor:   InGeneron, Inc.
Not yet recruiting - verified March 2017
Posted: Thursday, November 3, 2016 - 12:00
Condition:   Knee Osteoarthritis
Interventions:   Biological: BMAC injection;   Biological: PRP injection;   Device: Gel-One® hyaluronate injection
Sponsor:   OhioHealth
Not yet recruiting - verified November 2016
Posted: Thursday, November 3, 2016 - 12:00
Condition:   Bronchopleural Fistula
Intervention:   Biological: UCMSC
Sponsors:   The Second Affiliated Hospital of Fujian Medical University;   Shanghai iCELL Biotechnology Co., Ltd, Shanghai, China
Recruiting - verified November 2016
Posted: Tuesday, October 25, 2016 - 12:00
Condition:   Chronic Nasal Septum Perforation
Intervention:   Biological: Collagen membrane + HUC-MSCs
Sponsors:   Chinese Academy of Sciences;   The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Not yet recruiting - verified October 2016
Posted: Thursday, October 20, 2016 - 12:00
Conditions:   Corneal Injuries;   Corneal Burns;   Corneal Scars and Opacities
Intervention:   Biological: Ex-vivo cultivated limbal stem cell pool
Sponsor:   L.V. Prasad Eye Institute
Recruiting - verified October 2016
Posted: Thursday, October 13, 2016 - 12:00
Condition:   Moderate to Severe Chronic Kidney Disease
Intervention:   Drug: Elixcyte
Sponsors:   UnicoCell Biomed CO. LTD;   A2 Healthcare Taiwan Corporation
Not yet recruiting - verified October 2016
Posted: Monday, September 26, 2016 - 12:00
Condition:   Rotator Cuff Tear - Partial Thickness
Intervention:   Device: Adipose-derived stem cell injection
Sponsor:   InGeneron, Inc.
Not yet recruiting - verified September 2016
Posted: Tuesday, September 20, 2016 - 12:00
Condition:   Acute Traumatic Spinal Cord Injury
Interventions:   Drug: FAB117-HC;   Other: Control group;   Drug: FAB117-HC
Sponsors:   Ferrer Internacional S.A.;   Histocell S.L.
Not yet recruiting - verified September 2016
Posted: Friday, August 5, 2016 - 12:00
Condition:   Diabetic Foot Ulcer
Intervention:   Drug: adipose-derived regenerative cells (ADRCs)
Sponsor:   Assistance Publique Hopitaux De Marseille
Not yet recruiting - verified August 2016
Posted: Tuesday, June 7, 2016 - 12:00
Condition:   Humerus Fracture Displaced Proximal
Interventions:   Biological: BMC2012;   Device: beta-TCP
Sponsors:   Goethe University;   LOEWE CGT
Not yet recruiting - verified June 2016

Pages